T&R Biofab has harnessed the power of 3D printing technology to revolutionize the regeneration of living tissues. Our relentless pursuit of innovation has led us to develop and commercialize a range of advanced regenerative medicine technologies. These include ECM-based biosurgical solutions, 3D bioprinted organoids, and cell therapy utilizing induced pluripotent stem cells.
Central to our success is the development of our core technologies, encompassing biomaterials, cells, and related processes. Our dedication to pioneering cutting-edge research and innovation fuels our pursuit of becoming a global leader in regenerative medicine, firmly rooted in our technological competitiveness.
Our aspirations extend far beyond technological leadership. T&R Biofab is driven by a profound mission to contribute to the health and welfare of humanity, alleviating the burdens of life and healing those in pain. We invite you to join us as we shape a future where we can make a lasting impact on the world we live in.
Thank you for your steadfast partnership.
Central to our success is the development of our core technologies, encompassing biomaterials, cells, and related processes. Our dedication to pioneering cutting-edge research and innovation fuels our pursuit of becoming a global leader in regenerative medicine, firmly rooted in our technological competitiveness.
Our aspirations extend far beyond technological leadership. T&R Biofab is driven by a profound mission to contribute to the health and welfare of humanity, alleviating the burdens of life and healing those in pain. We invite you to join us as we shape a future where we can make a lasting impact on the world we live in.
Thank you for your steadfast partnership.
T&R Biofab CEO Wonsoo, Yun